Karolinska Institutet
Browse

A study of two major challenges in prostate cancer : effective chemo-prevention and overcoming resistance to hormonal and chemotherapy

Download (810.67 kB)
thesis
posted on 2024-09-03, 05:06 authored by Yuanjun Ma

For men, over the course of a lifetime the risk of developing prostate cancer is 1 in 9. Both the illness itself and treatment affect quality of life in multiple aspects, including urinary problems, pain, and sexual dysfunction. Current clinical challenges in this field include: inevitable drug resistance to treatments, lack of accurate diagnostic and prognostic biomarkers, as well as no common chemoprevention strategies. The aim of this thesis is therefore to identify transcript alternations associated with drug resistance (Study I and Study II), to evaluate potential drug targets for prostate cancer treatment (Study III), and to estimate the preventive effect of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) against prostate cancer (Study IV).

Castration resistance and docetaxel resistance are two significant issues that arise during prostate cancer disease progression. We employed next generation RNA sequencing technology to compare hormone-resistant (Study II) and docetaxel-resistant (Study I) vs respective sensitive cell lines, aiming to discover a potential drug target with the capability of prolonging the duration of hormone and docetaxel treatments before the cancer cells becoming resistant. The results showed that a variety of transcript alterations were obtained during resistance development, including mutations, altered gene expressions, and fusion transcripts. These alterations might be associated with drug resistance in prostate cancer.

As a rationale for Study III, we hypothesized that proteins that have never been reported as mutated in prostate cancer might play an important role in cancer progression through their essential function of maintaining cellular stability in cancer cells. Upon mutation, these genes would induce severe cellular instability such that the cells could not survive, and these cells would be erased through natural selection during cancer growth. In Study III, we therefore evaluated a non-mutated protein in prostate cancer, GPR89A, as a potential drug target with possible anti-cancer function.

Low-dose aspirin has been recommended by the U.S. Preventive Services Task Force (USPSTF) to prevent cardiovascular disease and colorectal cancer. However, results published in scientific studies are controversial regarding prostate cancer. In Study IV, we assessed whether maintenance use of aspirin or other NSAIDs could reduce the risk of prostate cancer. Based on data from the Swedish Cancer Register, the Swedish Prescribed Drug Register and the Swedish Causes of Death Register (2005-2012), we conducted a nationwide cohort study and found a protective effect of aspirin and other NSAIDs against prostate cancer, especially after long-term intake.

In sum, this thesis identified or assessed alternative methods against prostate cancer through exploring molecular approaches to develop more effective treatment methods, and by attempting to reduce the prevalence of cancer cases through chemoprevention.

List of scientific papers

I. Ma Y, Miao Y, Peng Z, Sandgren J, Ståhl T, Huss M, Lennartsson L, Liu Y, Nistér M, Nilsson S, Li C. Identification of mutations, gene expression changes and fusion transcripts by whole transcriptome RNAseq in docetaxel-resistant prostate cancer cells. Springerplus. 2016; 5(1): 1861-1872.
https://doi.org/10.1186/s40064-016-3543-0

II. Ma Y, Miao Y, Peng Z, Sandgren J, Ståhl T, Lennartsson L, Nilsson S, Li C. Identification of mutations, expression alterations and fusion transcripts by next generation RNAseq in castration-resistant prostate cancer cell lines with possible clinical relevance. Journal of Next Generation Sequencing & Applications. 2017; 4:2.
https://doi.org/10.4172/2469-9853.1000149

III. Ma Y, Liu Y, Liu J, Peng Z, Bajalica-Lagercrantz S, Nilsson S, Li C. Evaluation of GPR89A protein as drug targer in prostate cancer. [Manuscript]

IV. Ma Y, Brusselaers N. Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk. Prostate Cancer and Prostatic Disease. 2018; 21:147-152.
https://doi.org/10.1038/s41391-017-0021-x

History

Defence date

2018-08-28

Department

  • Department of Oncology-Pathology

Publisher/Institution

Karolinska Institutet

Main supervisor

Li, Chunde

Co-supervisors

Nilsson, Sten; Bajalica-Lagercrantz, Svetlana

Publication year

2018

Thesis type

  • Doctoral thesis

ISBN

978-91-7831-124-8

Number of supporting papers

4

Language

  • eng

Original publication date

2018-06-29

Author name in thesis

Ma, Yuanjun

Original department name

Department of Oncology-Pathology

Place of publication

Stockholm

Usage metrics

    Theses

    Categories

    No categories selected

    Keywords

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC